$HITK Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in HI TECH PHARMACAL CO INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in HI TECH PHARMACAL CO INC. Get notifications about new insider transactions in HI TECH PHARMACAL CO INC for free.
Page: < prev 1 2 3 4 5 6 6 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 16 2009 | HITK | HI TECH PHARMACAL ... | HIRSHAUT YASHAR | Director | Buy | M | 1.92 | 11,250 | 21,600 | 34,250 | 23 K to 34.3 K (+48.91 %) |
| Oct 16 2009 | HITK | HI TECH PHARMACAL ... | HIRSHAUT YASHAR | Director | Buy | M | 2.00 | 6,750 | 13,500 | 23,000 | 16.3 K to 23 K (+41.54 %) |
| Oct 16 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Option Exercise | M | 1.78 | 30,000 | 53,400 | 26,250 | |
| Oct 16 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 25.00 | 5,916 | 147,900 | 299,303 | 305.2 K to 299.3 K (-1.94 %) |
| Oct 16 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 24.91 | 30,000 | 747,300 | 493,535 | 523.5 K to 493.5 K (-5.73 %) |
| Oct 16 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Buy | M | 1.78 | 30,000 | 53,400 | 523,535 | 493.5 K to 523.5 K (+6.08 %) |
| Oct 15 2009 | HITK | HI TECH PHARMACAL ... | PETERS WILLIAM J | VP and Chief Financ ... | Option Exercise | M | 18.87 | 18,750 | 353,813 | 18,750 | |
| Oct 15 2009 | HITK | HI TECH PHARMACAL ... | PETERS WILLIAM J | VP and Chief Financ ... | Option Exercise | M | 19.95 | 1,508 | 30,085 | 7,500 | |
| Oct 15 2009 | HITK | HI TECH PHARMACAL ... | PETERS WILLIAM J | VP and Chief Financ ... | Option Exercise | M | 19.95 | 5,992 | 119,540 | 9,008 | |
| Oct 15 2009 | HITK | HI TECH PHARMACAL ... | PETERS WILLIAM J | VP and Chief Financ ... | Sell | S | 25.07 | 20,258 | 507,868 | 0 | 20.3 K to 0 (-100.00 %) |
| Oct 15 2009 | HITK | HI TECH PHARMACAL ... | PETERS WILLIAM J | VP and Chief Financ ... | Buy | M | 18.87 | 18,750 | 353,813 | 20,258 | 1.5 K to 20.3 K (+1,243.37 %) |
| Oct 15 2009 | HITK | HI TECH PHARMACAL ... | PETERS WILLIAM J | VP and Chief Financ ... | Buy | M | 19.95 | 1,508 | 30,085 | 1,508 | 0 to 1.5 K |
| Oct 15 2009 | HITK | HI TECH PHARMACAL ... | PETERS WILLIAM J | VP and Chief Financ ... | Sell | S | 25.00 | 5,992 | 149,800 | 0 | 6 K to 0 (-100.00 %) |
| Oct 15 2009 | HITK | HI TECH PHARMACAL ... | PETERS WILLIAM J | VP and Chief Financ ... | Buy | M | 19.95 | 5,992 | 119,540 | 5,992 | 0 to 6 K |
| Oct 08 2009 | HITK | HI TECH PHARMACAL ... | SELTZER DAVID S | CEO, President, Sec ... | Sell | S | 23.30 | 2,500 | 58,250 | 46,144 | 48.6 K to 46.1 K (-5.14 %) |
| Oct 08 2009 | HITK | HI TECH PHARMACAL ... | SELTZER DAVID S | CEO, President, Sec ... | Sell | S | 23.22 | 2,500 | 58,050 | 43,468 | 46 K to 43.5 K (-5.44 %) |
| Oct 08 2009 | HITK | HI TECH PHARMACAL ... | SELTZER DAVID S | CEO, President, Sec ... | Sell | S | 23.42 | 5,000 | 117,100 | 221,402 | 226.4 K to 221.4 K (-2.21 %) |
| Oct 08 2009 | HITK | HI TECH PHARMACAL ... | SELTZER DAVID S | CEO, President, Sec ... | Sell | S | 24.02 | 5,000 | 120,100 | 1,167,120 | 1.2 M to 1.2 M (-0.43 %) |
| Oct 08 2009 | HITK | HI TECH PHARMACAL ... | SELTZER DAVID S | CEO, President, Sec ... | Sell | S | 23.33 | 15,000 | 349,950 | 1,172,120 | 1.2 M to 1.2 M (-1.26 %) |
| Oct 07 2009 | HITK | HI TECH PHARMACAL ... | PETERS WILLIAM J | VP and Chief Financ ... | Option Exercise | M | 15.09 | 1,950 | 29,426 | 6,250 | |
| Oct 07 2009 | HITK | HI TECH PHARMACAL ... | PETERS WILLIAM J | VP and Chief Financ ... | Sell | S | 23.26 | 1,950 | 45,357 | 0 | 2 K to 0 (-100.00 %) |
| Oct 07 2009 | HITK | HI TECH PHARMACAL ... | PETERS WILLIAM J | VP and Chief Financ ... | Buy | M | 15.09 | 1,950 | 29,426 | 1,950 | 0 to 2 K |
| Oct 02 2009 | HITK | HI TECH PHARMACAL ... | PETERS WILLIAM J | VP and Chief Financ ... | Option Exercise | M | 15.09 | 10,800 | 162,972 | 8,200 | |
| Oct 02 2009 | HITK | HI TECH PHARMACAL ... | PETERS WILLIAM J | VP and Chief Financ ... | Sell | S | 22.81 | 10,800 | 246,348 | 0 | 10.8 K to 0 (-100.00 %) |
| Oct 02 2009 | HITK | HI TECH PHARMACAL ... | PETERS WILLIAM J | VP and Chief Financ ... | Buy | M | 15.09 | 10,800 | 162,972 | 10,800 | 0 to 10.8 K |
| Oct 01 2009 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Option Exercise | M | 8.31 | 1,000 | 8,310 | 8,500 | |
| Oct 01 2009 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Sell | S | 22.11 | 1,000 | 22,110 | 0 | 1,000 to 0 (-100.00 %) |
| Oct 01 2009 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Buy | M | 8.31 | 1,000 | 8,310 | 1,000 | 0 to 1,000 |
| Oct 01 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 21.57 | 16,556 | 357,113 | 305,119 | 321.7 K to 305.1 K (-5.15 %) |
| Oct 01 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 22.90 | 6,845 | 156,751 | 493,535 | 500.4 K to 493.5 K (-1.37 %) |
| Oct 01 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 21.40 | 12,000 | 256,800 | 500,380 | 512.4 K to 500.4 K (-2.34 %) |
| Sep 30 2009 | HITK | HI TECH PHARMACAL ... | SELTZER DAVID S | CEO, President, Sec ... | Sell | S | 21.56 | 7,500 | 161,700 | 48,644 | 56.1 K to 48.6 K (-13.36 %) |
| Sep 30 2009 | HITK | HI TECH PHARMACAL ... | SELTZER DAVID S | CEO, President, Sec ... | Sell | S | 21.50 | 7,500 | 161,250 | 45,968 | 53.5 K to 46 K (-14.03 %) |
| Sep 30 2009 | HITK | HI TECH PHARMACAL ... | SELTZER DAVID S | CEO, President, Sec ... | Sell | S | 21.46 | 5,000 | 107,300 | 226,402 | 231.4 K to 226.4 K (-2.16 %) |
| Sep 30 2009 | HITK | HI TECH PHARMACAL ... | SELTZER DAVID S | CEO, President, Sec ... | Sell | S | 21.47 | 20,000 | 429,400 | 1,187,120 | 1.2 M to 1.2 M (-1.66 %) |
| Sep 30 2009 | HITK | HI TECH PHARMACAL ... | SELTZER DAVID S | CEO, President, Sec ... | Gift | G | 0.00 | 5,000 | 0 | 1,279,996 | 1.3 M to 1.3 M (-0.39 %) |
| Sep 18 2009 | HITK | HI TECH PHARMACAL ... | April Gary M | President, HCP Divi ... | Option Exercise | M | 8.31 | 16,875 | 140,231 | 0 | |
| Sep 18 2009 | HITK | HI TECH PHARMACAL ... | April Gary M | President, HCP Divi ... | Option Exercise | M | 3.84 | 33,750 | 129,600 | 0 | |
| Sep 18 2009 | HITK | HI TECH PHARMACAL ... | April Gary M | President, HCP Divi ... | Option Exercise | M | 1.78 | 4,218 | 7,508 | 0 | |
| Sep 18 2009 | HITK | HI TECH PHARMACAL ... | April Gary M | President, HCP Divi ... | Sell | S | 19.31 | 16,875 | 325,856 | 0 | 16.9 K to 0 (-100.00 %) |
| Sep 18 2009 | HITK | HI TECH PHARMACAL ... | April Gary M | President, HCP Divi ... | Buy | M | 8.31 | 16,875 | 140,231 | 16,875 | 0 to 16.9 K |
| Sep 18 2009 | HITK | HI TECH PHARMACAL ... | April Gary M | President, HCP Divi ... | Sell | S | 21.14 | 37,968 | 802,644 | 0 | 38 K to 0 (-100.00 %) |
| Sep 18 2009 | HITK | HI TECH PHARMACAL ... | April Gary M | President, HCP Divi ... | Buy | M | 3.84 | 33,750 | 129,600 | 37,968 | 4.2 K to 38 K (+800.14 %) |
| Sep 18 2009 | HITK | HI TECH PHARMACAL ... | April Gary M | President, HCP Divi ... | Buy | M | 1.78 | 4,218 | 7,508 | 4,218 | 0 to 4.2 K |
| Sep 18 2009 | HITK | HI TECH PHARMACAL ... | Simpson Bruce W | Director | Option Exercise | M | 9.65 | 3,094 | 29,857 | 9,281 | |
| Sep 18 2009 | HITK | HI TECH PHARMACAL ... | Simpson Bruce W | Director | Option Exercise | M | 10.93 | 12,093 | 132,176 | 0 | |
| Sep 18 2009 | HITK | HI TECH PHARMACAL ... | Simpson Bruce W | Director | Sell | S | 19.13 | 15,187 | 290,527 | 0 | 15.2 K to 0 (-100.00 %) |
| Sep 18 2009 | HITK | HI TECH PHARMACAL ... | Simpson Bruce W | Director | Buy | M | 9.65 | 3,094 | 29,857 | 15,187 | 12.1 K to 15.2 K (+25.59 %) |
| Sep 18 2009 | HITK | HI TECH PHARMACAL ... | Simpson Bruce W | Director | Buy | M | 10.93 | 12,093 | 132,176 | 12,093 | 0 to 12.1 K |
| Sep 16 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 21.04 | 27,000 | 568,080 | 321,675 | 348.7 K to 321.7 K (-7.74 %) |
| Sep 16 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 21.00 | 20,000 | 420,000 | 512,380 | 532.4 K to 512.4 K (-3.76 %) |
| Sep 16 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 21.00 | 25,000 | 525,000 | 532,380 | 557.4 K to 532.4 K (-4.49 %) |
| Sep 15 2009 | HITK | HI TECH PHARMACAL ... | SELTZER DAVID S | CEO, President, Sec ... | Sell | S | 20.74 | 5,000 | 103,700 | 72,148 | 77.1 K to 72.1 K (-6.48 %) |
| Sep 15 2009 | HITK | HI TECH PHARMACAL ... | SELTZER DAVID S | CEO, President, Sec ... | Sell | S | 20.75 | 5,000 | 103,750 | 56,144 | 61.1 K to 56.1 K (-8.18 %) |
| Sep 15 2009 | HITK | HI TECH PHARMACAL ... | SELTZER DAVID S | CEO, President, Sec ... | Sell | S | 20.28 | 5,000 | 101,400 | 212,722 | 217.7 K to 212.7 K (-2.30 %) |
| Sep 15 2009 | HITK | HI TECH PHARMACAL ... | SELTZER DAVID S | CEO, President, Sec ... | Sell | S | 20.25 | 5,000 | 101,250 | 217,722 | 222.7 K to 217.7 K (-2.24 %) |
| Sep 15 2009 | HITK | HI TECH PHARMACAL ... | SELTZER DAVID S | CEO, President, Sec ... | Sell | S | 20.72 | 25,000 | 518,000 | 1,212,120 | 1.2 M to 1.2 M (-2.02 %) |
| Sep 15 2009 | HITK | HI TECH PHARMACAL ... | SELTZER DAVID S | CEO, President, Sec ... | Sell | S | 20.79 | 33,776 | 702,203 | 1,237,120 | 1.3 M to 1.2 M (-2.66 %) |
| Sep 15 2009 | HITK | HI TECH PHARMACAL ... | SELTZER DAVID S | CEO, President, Sec ... | Sell | S | 20.42 | 14,100 | 287,922 | 1,270,896 | 1.3 M to 1.3 M (-1.10 %) |
| Sep 15 2009 | HITK | HI TECH PHARMACAL ... | SELTZER DAVID S | CEO, President, Sec ... | Sell | S | 21.66 | 60,900 | 1,319,094 | 1,284,996 | 1.3 M to 1.3 M (-4.52 %) |
| Sep 15 2009 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Option Exercise | M | 4.29 | 2,304 | 9,884 | 3,885 | |
| Sep 15 2009 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Option Exercise | M | 1.92 | 1,676 | 3,218 | 2,824 | |
| Sep 15 2009 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Option Exercise | M | 8.31 | 2,000 | 16,620 | 9,500 | |
| Sep 15 2009 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Option Exercise | M | 8.31 | 2,000 | 16,620 | 11,500 | |
| Sep 15 2009 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Option Exercise | M | 4.29 | 2,811 | 12,059 | 6,189 | |
| Sep 15 2009 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Sell | J | 0.00 | 3,980 | 0 | 0 | 4 K to 0 (-100.00 %) |
| Sep 15 2009 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Buy | M | 4.29 | 2,304 | 9,884 | 3,980 | 1.7 K to 4 K (+137.47 %) |
| Sep 15 2009 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Buy | M | 1.92 | 1,676 | 3,218 | 1,676 | 0 to 1.7 K |
| Sep 15 2009 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Sell | S | 20.82 | 2,000 | 41,640 | 0 | 2 K to 0 (-100.00 %) |
| Sep 15 2009 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Buy | M | 8.31 | 2,000 | 16,620 | 2,000 | 0 to 2 K |
| Sep 15 2009 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Sell | S | 21.31 | 4,811 | 102,522 | 0 | 4.8 K to 0 (-100.00 %) |
| Sep 15 2009 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Buy | M | 8.31 | 2,000 | 16,620 | 4,811 | 2.8 K to 4.8 K (+71.15 %) |
| Sep 15 2009 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Buy | M | 4.29 | 2,811 | 12,059 | 2,811 | 0 to 2.8 K |
| Sep 15 2009 | HITK | HI TECH PHARMACAL ... | PETERS WILLIAM J | VP and Chief Financ ... | Option Exercise | M | 10.68 | 6,250 | 66,750 | 18,750 | |
| Sep 15 2009 | HITK | HI TECH PHARMACAL ... | PETERS WILLIAM J | VP and Chief Financ ... | Option Exercise | M | 10.68 | 12,500 | 133,500 | 12,500 | |
| Sep 15 2009 | HITK | HI TECH PHARMACAL ... | PETERS WILLIAM J | VP and Chief Financ ... | Option Exercise | M | 15.09 | 6,000 | 90,540 | 19,000 | |
| Sep 15 2009 | HITK | HI TECH PHARMACAL ... | PETERS WILLIAM J | VP and Chief Financ ... | Option Exercise | M | 10.13 | 31,500 | 319,095 | 0 | |
| Sep 15 2009 | HITK | HI TECH PHARMACAL ... | PETERS WILLIAM J | VP and Chief Financ ... | Sell | S | 21.86 | 56,250 | 1,229,625 | 0 | 56.3 K to 0 (-100.00 %) |
| Sep 15 2009 | HITK | HI TECH PHARMACAL ... | PETERS WILLIAM J | VP and Chief Financ ... | Buy | M | 10.68 | 6,250 | 66,750 | 56,250 | 50 K to 56.3 K (+12.50 %) |
| Sep 15 2009 | HITK | HI TECH PHARMACAL ... | PETERS WILLIAM J | VP and Chief Financ ... | Buy | M | 10.68 | 12,500 | 133,500 | 50,000 | 37.5 K to 50 K (+33.33 %) |
| Sep 15 2009 | HITK | HI TECH PHARMACAL ... | PETERS WILLIAM J | VP and Chief Financ ... | Buy | M | 15.09 | 6,000 | 90,540 | 37,500 | 31.5 K to 37.5 K (+19.05 %) |
| Sep 15 2009 | HITK | HI TECH PHARMACAL ... | PETERS WILLIAM J | VP and Chief Financ ... | Buy | M | 10.13 | 31,500 | 319,095 | 31,500 | 0 to 31.5 K |
| Jul 28 2009 | HITK | HI TECH PHARMACAL ... | HIRSHAUT YASHAR | Director | Sell | S | 13.00 | 10,000 | 130,000 | 16,250 | 26.3 K to 16.3 K (-38.10 %) |
| Jul 20 2009 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Option Exercise | M | 2.00 | 1,652 | 3,304 | 0 | |
| Jul 20 2009 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Sell | J | 0.00 | 1,652 | 0 | 0 | 1.7 K to 0 (-100.00 %) |
| Jul 20 2009 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Buy | M | 2.00 | 1,652 | 3,304 | 1,652 | 0 to 1.7 K |
| Jul 20 2009 | HITK | HI TECH PHARMACAL ... | Harvey Bryce M | Officer | Sell | S | 13.25 | 1,672 | 22,154 | 0 | 1.7 K to 0 (-100.00 %) |
| Jul 20 2009 | HITK | HI TECH PHARMACAL ... | Harvey Bryce M | Officer | Sell | S | 13.18 | 328 | 4,323 | 1,672 | 2 K to 1.7 K (-16.40 %) |
| Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Option Exercise | M | 2.00 | 6,750 | 13,500 | 0 | |
| Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | M | 12.77 | 6,750 | 86,198 | 557,380 | 564.1 K to 557.4 K (-1.20 %) |
| Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Buy | M | 2.00 | 6,750 | 13,500 | 564,130 | 557.4 K to 564.1 K (+1.21 %) |
| Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 12.75 | 51,239 | 653,297 | 557,380 | 608.6 K to 557.4 K (-8.42 %) |
| Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 12.76 | 1,110 | 14,164 | 608,619 | 609.7 K to 608.6 K (-0.18 %) |
| Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 12.77 | 5,000 | 63,850 | 609,729 | 614.7 K to 609.7 K (-0.81 %) |
| Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 12.80 | 2,224 | 28,467 | 614,729 | 617 K to 614.7 K (-0.36 %) |
| Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 12.81 | 400 | 5,124 | 616,953 | 617.4 K to 617 K (-0.06 %) |
| Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 12.82 | 1,200 | 15,384 | 617,353 | 618.6 K to 617.4 K (-0.19 %) |
| Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 12.83 | 800 | 10,264 | 618,553 | 619.4 K to 618.6 K (-0.13 %) |
| Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 12.84 | 250 | 3,210 | 619,353 | 619.6 K to 619.4 K (-0.04 %) |
| Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 12.85 | 500 | 6,425 | 619,603 | 620.1 K to 619.6 K (-0.08 %) |
| Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 12.91 | 600 | 7,746 | 620,103 | 620.7 K to 620.1 K (-0.10 %) |
| Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 12.96 | 2,452 | 31,778 | 620,703 | 623.2 K to 620.7 K (-0.39 %) |
| Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 12.97 | 600 | 7,782 | 623,155 | 623.8 K to 623.2 K (-0.10 %) |
| Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 13.00 | 2,200 | 28,600 | 623,755 | 626 K to 623.8 K (-0.35 %) |
| Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 13.01 | 600 | 7,806 | 625,955 | 626.6 K to 626 K (-0.10 %) |
| Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 13.02 | 300 | 3,906 | 626,555 | 626.9 K to 626.6 K (-0.05 %) |
| Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 13.03 | 1,400 | 18,242 | 626,855 | 628.3 K to 626.9 K (-0.22 %) |
| Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 13.05 | 200 | 2,610 | 628,255 | 628.5 K to 628.3 K (-0.03 %) |
| Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 13.06 | 500 | 6,530 | 628,455 | 629 K to 628.5 K (-0.08 %) |
| Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 13.07 | 840 | 10,979 | 628,955 | 629.8 K to 629 K (-0.13 %) |
| Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 13.08 | 500 | 6,540 | 629,795 | 630.3 K to 629.8 K (-0.08 %) |
| Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 13.10 | 100 | 1,310 | 630,295 | 630.4 K to 630.3 K (-0.02 %) |
| Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 13.15 | 710 | 9,337 | 630,395 | 631.1 K to 630.4 K (-0.11 %) |
| Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 13.18 | 100 | 1,318 | 631,105 | 631.2 K to 631.1 K (-0.02 %) |
| Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 13.19 | 275 | 3,627 | 631,205 | 631.5 K to 631.2 K (-0.04 %) |
| Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 13.20 | 500 | 6,600 | 631,480 | 632 K to 631.5 K (-0.08 %) |
| Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 13.21 | 100 | 1,321 | 631,980 | 632.1 K to 632 K (-0.02 %) |
| Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 13.22 | 300 | 3,966 | 632,080 | 632.4 K to 632.1 K (-0.05 %) |
| Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER DAVID S | CEO, President, Sec ... | Sell | S | 12.50 | 4,050 | 50,625 | 1,345,896 | 1.3 M to 1.3 M (-0.30 %) |
| Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER DAVID S | CEO, President, Sec ... | Sell | S | 12.51 | 100 | 1,251 | 1,349,946 | 1.4 M to 1.3 M (-0.01 %) |
| Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER DAVID S | CEO, President, Sec ... | Sell | S | 12.52 | 500 | 6,260 | 1,350,046 | 1.4 M to 1.4 M (-0.04 %) |
| Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER DAVID S | CEO, President, Sec ... | Sell | S | 12.53 | 600 | 7,518 | 1,350,546 | 1.4 M to 1.4 M (-0.04 %) |
| Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER DAVID S | CEO, President, Sec ... | Sell | S | 12.54 | 100 | 1,254 | 1,351,146 | 1.4 M to 1.4 M (-0.01 %) |
| Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER DAVID S | CEO, President, Sec ... | Sell | S | 12.58 | 1,280 | 16,102 | 1,351,246 | 1.4 M to 1.4 M (-0.09 %) |
| Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER DAVID S | CEO, President, Sec ... | Sell | S | 12.59 | 100 | 1,259 | 1,352,526 | 1.4 M to 1.4 M (-0.01 %) |
| Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER DAVID S | CEO, President, Sec ... | Sell | S | 12.60 | 800 | 10,080 | 1,352,626 | 1.4 M to 1.4 M (-0.06 %) |
| Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER DAVID S | CEO, President, Sec ... | Sell | S | 12.75 | 4,176 | 53,244 | 1,353,426 | 1.4 M to 1.4 M (-0.31 %) |
| Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER DAVID S | CEO, President, Sec ... | Sell | S | 12.76 | 518 | 6,610 | 1,357,602 | 1.4 M to 1.4 M (-0.04 %) |
| Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER DAVID S | CEO, President, Sec ... | Sell | S | 12.77 | 700 | 8,939 | 1,358,120 | 1.4 M to 1.4 M (-0.05 %) |
| Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER DAVID S | CEO, President, Sec ... | Sell | S | 12.78 | 700 | 8,946 | 1,358,820 | 1.4 M to 1.4 M (-0.05 %) |
| Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER DAVID S | CEO, President, Sec ... | Sell | S | 12.79 | 500 | 6,395 | 1,359,520 | 1.4 M to 1.4 M (-0.04 %) |
| Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER DAVID S | CEO, President, Sec ... | Sell | S | 12.81 | 1,400 | 17,934 | 1,360,020 | 1.4 M to 1.4 M (-0.10 %) |
| Jul 20 2009 | HITK | HI TECH PHARMACAL ... | SELTZER DAVID S | CEO, President, Sec ... | Sell | S | 12.82 | 700 | 8,974 | 1,361,420 | 1.4 M to 1.4 M (-0.05 %) |
| Mar 27 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Option Exercise | M | 1.64 | 56,250 | 92,250 | 0 | |
| Mar 27 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Buy | M | 1.64 | 56,250 | 92,250 | 629,890 | 573.6 K to 629.9 K (+9.81 %) |
| Mar 27 2009 | HITK | HI TECH PHARMACAL ... | SELTZER DAVID S | CEO, President, Sec ... | Option Exercise | M | 1.64 | 112,500 | 184,500 | 0 | |
| Mar 27 2009 | HITK | HI TECH PHARMACAL ... | SELTZER DAVID S | CEO, President, Sec ... | Buy | M | 1.64 | 112,500 | 184,500 | 1,359,630 | 1.2 M to 1.4 M (+9.02 %) |
| Nov 17 2008 | HITK | HI TECH PHARMACAL ... | Simpson Bruce W | Director | Option Exercise | A | 5.83 | 12,375 | 72,146 | 12,375 | |
| Nov 17 2008 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Option Exercise | A | 5.83 | 25,000 | 145,750 | 25,000 | |
| Nov 17 2008 | HITK | HI TECH PHARMACAL ... | HIRSHAUT YASHAR | Director | Option Exercise | A | 5.83 | 11,250 | 65,588 | 11,250 | |
| Nov 17 2008 | HITK | HI TECH PHARMACAL ... | PUGLISI ANTHONY J | Director | Option Exercise | A | 5.83 | 12,375 | 72,146 | 12,375 | |
| Nov 17 2008 | HITK | HI TECH PHARMACAL ... | SELTZER DAVID S | CEO, President, Sec ... | Option Exercise | A | 5.83 | 50,000 | 291,500 | 50,000 | |
| Nov 17 2008 | HITK | HI TECH PHARMACAL ... | Van Hulst Jack | Director | Option Exercise | A | 5.83 | 12,375 | 72,146 | 12,375 | |
| Nov 17 2008 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Option Exercise | A | 5.83 | 11,250 | 65,588 | 11,250 | |
| Nov 17 2008 | HITK | HI TECH PHARMACAL ... | PETERS WILLIAM J | VP and Chief Financ ... | Option Exercise | A | 5.83 | 25,000 | 145,750 | 25,000 | |
| Oct 24 2008 | HITK | HI TECH PHARMACAL ... | HIRSHAUT YASHAR | Director | Option Exercise | M | 1.89 | 4,250 | 8,033 | 0 | |
| Oct 24 2008 | HITK | HI TECH PHARMACAL ... | HIRSHAUT YASHAR | Director | Buy | M | 1.89 | 4,250 | 8,033 | 26,250 | 22 K to 26.3 K (+19.32 %) |
| Sep 16 2008 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Option Exercise | A | 9.70 | 25,000 | 242,500 | 25,000 | |
| Jul 21 2008 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Option Exercise | M | 1.89 | 6,750 | 12,758 | 0 | |
| Jul 21 2008 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | M | 10.69 | 12 | 128 | 573,640 | 573.7 K to 573.6 K (0.00 %) |